Cromwell Holdings’s AbbVie ABBV Stock Holding History

Cromwell Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.48M	Buy	5,893 +663	+13%	+$143K	0.67%	26
2026 Q1	$1.14M	Hold	5,230	–	–	0.64%	20
2025 Q4	$1.2M	Hold	5,230	–	–	0.65%	18
2025 Q3	$1.21M	Hold	5,230	–	–	0.65%	21
2025 Q2	$971K	Hold	5,230	–	–	0.59%	21
2025 Q1	$1.1M	Hold	5,230	–	–	0.7%	21
2024 Q4	$929K	Hold	5,230	–	–	0.54%	28
2024 Q3	$1.03M	Hold	5,230	–	–	0.66%	20
2024 Q2	$897K	Buy	+5,230	New	+$866K	0.54%	27

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cromwell Holdings's ABBV Position: Q2 2026 in Review

Cromwell Holdings increased its AbbVie (ABBV) stake by 13% in Q2 2026, buying an estimated $143K and bringing the position to 5,893 shares worth $1.48M. The position accounts for 0.67% of the portfolio, ranked #26.

Cromwell Holdings first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cromwell Holdings held 5,893 shares of AbbVie worth $1.48M as of Q2 2026.
Cromwell Holdings bought 663 AbbVie shares in Q2 2026, an estimated $143K.
AbbVie made up 0.67% of Cromwell Holdings's portfolio in Q2 2026, its #26 holding.
Cromwell Holdings first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.